IN2014MN00949A - - Google Patents

Info

Publication number
IN2014MN00949A
IN2014MN00949A IN949MUN2014A IN2014MN00949A IN 2014MN00949 A IN2014MN00949 A IN 2014MN00949A IN 949MUN2014 A IN949MUN2014 A IN 949MUN2014A IN 2014MN00949 A IN2014MN00949 A IN 2014MN00949A
Authority
IN
India
Prior art keywords
interleukin
chain
relates
coagulation factor
factor xiii
Prior art date
Application number
Other languages
English (en)
Inventor
Joseph Anderberg
Jeff Gray
Paul Mcpherson
Kevin Nakamura
James Patrick Kampf
Original Assignee
Astute Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical Inc filed Critical Astute Medical Inc
Publication of IN2014MN00949A publication Critical patent/IN2014MN00949A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
IN949MUN2014 2011-11-22 2012-11-20 IN2014MN00949A (ko)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US201161562872P 2011-11-22 2011-11-22
US201161562916P 2011-11-22 2011-11-22
US201161562778P 2011-11-22 2011-11-22
US201161562947P 2011-11-22 2011-11-22
US201161562879P 2011-11-22 2011-11-22
US201161562824P 2011-11-22 2011-11-22
US201161562885P 2011-11-22 2011-11-22
US201161562802P 2011-11-22 2011-11-22
US201161562829P 2011-11-22 2011-11-22
US201161562817P 2011-11-22 2011-11-22
US201161562813P 2011-11-22 2011-11-22
US201161562943P 2011-11-22 2011-11-22
US201161562951P 2011-11-22 2011-11-22
US201161562883P 2011-11-22 2011-11-22
PCT/US2012/066152 WO2013078253A1 (en) 2011-11-22 2012-11-20 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Publications (1)

Publication Number Publication Date
IN2014MN00949A true IN2014MN00949A (ko) 2015-04-24

Family

ID=48470273

Family Applications (1)

Application Number Title Priority Date Filing Date
IN949MUN2014 IN2014MN00949A (ko) 2011-11-22 2012-11-20

Country Status (6)

Country Link
US (2) US20140315752A1 (ko)
EP (2) EP2783213B1 (ko)
AU (1) AU2012340748A1 (ko)
CA (1) CA2856399A1 (ko)
IN (1) IN2014MN00949A (ko)
WO (1) WO2013078253A1 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150017671A1 (en) 2004-04-16 2015-01-15 Yaping Shou Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity
US20160146832A1 (en) * 2013-06-05 2016-05-26 Lakhmir S. Chawla Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20160282344A1 (en) * 2013-11-15 2016-09-29 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of sepsis
EP3922259A1 (en) 2014-10-30 2021-12-15 Acceleron Pharma Inc. Methods and compositions using gdf15 polypeptides for increasing red blood cells
US11143659B2 (en) 2015-01-27 2021-10-12 Arterez, Inc. Biomarkers of vascular disease
US20230059874A1 (en) 2019-12-23 2023-02-23 FUNDACIÓ INSTITUT D'INVESTIGACIÓ EN CIÈNCIES DE LA SALUT GERMANS TRIAS l PUJOL (IGTP) New protein markers of renal damage

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
JPH05504841A (ja) 1990-09-14 1993-07-22 バイオサイト・ダイアグノスティックス・インコーポレイテッド リガンドレセプター及びリガンドのコンプレックスに対する抗体及びリガンド―レセプターアッセーでのそれらの用途
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
DE69228682T2 (de) 1991-04-10 1999-07-01 Biosite Diagnostics Inc., San Diego, Calif. "crosstalk"- oder übersprech-inhibitoren und ihre verwendung
WO1992018866A1 (en) 1991-04-10 1992-10-29 Biosite Diagnostics Incorporated Novel conjugates and assays for simultaneous detection of multiple ligands
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US5885527A (en) 1992-05-21 1999-03-23 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membrances
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
US20040009171A1 (en) * 2001-10-18 2004-01-15 Genentech, Inc. Methods for the treatment of carcinoma
AU2006210794A1 (en) * 2005-02-01 2006-08-10 Government Of The U.S.A., As Represented By The Secretary, Department Of Health & Human Services Biomarkers for tissue status
WO2008060607A2 (en) * 2006-11-14 2008-05-22 Biosite Incorporated Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
US8221995B2 (en) * 2007-03-23 2012-07-17 Seok-Won Lee Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
AU2009285550B2 (en) * 2008-08-28 2015-06-18 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2350669B9 (en) * 2008-10-31 2014-06-11 St Vincent's Hospital Sydney Limited Methods of prognosis in chronic kidney disease
EP3246708A3 (en) * 2009-12-18 2018-01-03 Roche Diagnostics GmbH Troponins for predicting kidney failure in heart surgery patients
CA2784889C (en) * 2009-12-20 2018-06-19 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Also Published As

Publication number Publication date
EP3282257A1 (en) 2018-02-14
WO2013078253A1 (en) 2013-05-30
CA2856399A1 (en) 2013-05-30
EP2783213B1 (en) 2017-09-13
EP2783213A4 (en) 2015-09-09
EP2783213A1 (en) 2014-10-01
US20170336421A1 (en) 2017-11-23
US20140315752A1 (en) 2014-10-23
NZ625725A (en) 2016-09-30
AU2012340748A1 (en) 2014-06-26

Similar Documents

Publication Publication Date Title
IN2014MN00949A (ko)
MX341191B (es) Metodos y composiciones para diagnostico y prognosis de lesion renal y falla renal.
IN2014MN00377A (ko)
MX2011004767A (es) Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
NZ630277A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
BRPI0707645B8 (pt) métodos in vitro para detecção de câncer em um indivíduo e para avaliação de prognóstico de um indivíduo tendo, ou suspeito de ter, câncer ovariano
NZ701807A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ592552A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ593514A (en) p-mTOR and p-AKT as Ratio Based Biomarkers for the Prognosis and/or Diagnosis of Cancer
MX2011008323A (es) Metodos y composiciones para diagnosis y prognosis de lesion renal y falla renal.
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ATE471512T1 (de) Verwendung des proteins s100a 12 als marker für kolorektalkarzinom
ATE554389T1 (de) Apex als marker für lungenkrebs
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
DE602006021038D1 (de) Verfahren zur diagnose eines ovarialkarzinoms
EP2585826A4 (en) METHODS AND COMPOSITIONS FOR DIAGNOSING AND PROGNOSING RENAL INJURY AND RENAL FAILURE
WO2006092729A3 (en) Novel biomarkers for diagnosis and/or prognosis or prognosis of neoplasias in animals
WO2012094658A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
IN2014MN01759A (ko)
NZ703055A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
ATE353544T1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
ATE359516T1 (de) Verwendung des proteins crabp ii (cellular retinoic acid-binding protein ii) als marker für brustkrebs